Kymera Therapeutics target price raised to $150 from $136 by Truist Securities
KYMR•Truist Securities raised its target price for Kymera Therapeutics to $150 from $136.
KYMR•KYMR•KYMR•Truist Securities raised its target price for Kymera Therapeutics to $150 from $136.
